Most recently, Mylan has faced anti-competition allegations. Last September, the New York Attorney General said its office had begun to investigate whether the company had entered into anti-competitive bidding practices over its sales of the devices to New York school districts. In addition, the Federal Trade Commission has been looking into whether the company violated antitrust laws to shield the EpiPen from competition.
Copyright National Law Journal. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
